Mesalazine for diverticular disease of the colon – a new role for an old drug

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.1, 2005-01, pp. : 69-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mesalazine and Lactobacillus casei, alone or in combination, prevent recurrence of symptomatic uncomplicated diverticular colon disease

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Epidemiology and Management of Diverticular Disease of the Colon

By Kang J-Y.

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 211-228

Adis International

Access to resources Recommend Favorite

New physiopathological and therapeutic approaches to diverticular disease: an update

By Tursi Antonio

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1005-1017

Informa Healthcare

Access to resources Recommend Favorite

Alzheimers Disease Drug Development: Old Problems Require New Priorities

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 6, 2008-12 ,pp. : 499-511

Bentham Science Publishers

Access to resources Recommend Favorite

Teaching an old drug new tricks

By Rappocciolo E.

Drug Discovery Today, Vol. 9, Iss. 2, 2004-01 ,pp. : 54-54

Elsevier

Access to resources Recommend Favorite